-
Tetsuya Sugiyama
From the Department of Ophthalmology, Osaka Medical College, Japan; the
-
Hideaki Hara
Glaucoma Group, Ophthalmic Research Division, Santen Pharmaceutical Co., Ltd., Nara, Japan; and the
-
Hidehiro Oku
From the Department of Ophthalmology, Osaka Medical College, Japan; the
-
Shunji Nakatsuji
Department of Pathology, Toxicology Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
-
Takashi Okuno
From the Department of Ophthalmology, Osaka Medical College, Japan; the
-
Masaaki Sasaoka
Glaucoma Group, Ophthalmic Research Division, Santen Pharmaceutical Co., Ltd., Nara, Japan; and the
-
Takashi Ota
Glaucoma Group, Ophthalmic Research Division, Santen Pharmaceutical Co., Ltd., Nara, Japan; and the
-
Tsunehiko Ikeda
From the Department of Ophthalmology, Osaka Medical College, Japan; the